| Genetic instability and mammary tumor formation in mice carrying mammary-specific disruption of Chk1 and p53. | |
| | |
MedLine Citation:
|
PMID: 20473325 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Checkpoint kinase 1 (Chk1) is a key element in the DNA-damage response pathway that is required for maintaining genomic stability. To study the potential role of Chk1 in mammary tumorigenesis, we disrupted it using a Cre/loxP system. We showed that although Chk1 heterozygosity caused abnormal development of the mammary gland, it was not sufficient to induce tumorigenesis. Simultaneous deletion of one copy of p53 failed to rescue the developmental defects; however, it synergistically induced mammary tumor formation in Chk1(+/-);MMTV-Cre animals with a median time to tumor latency of about 10 months. Chk1 deficiency caused a preponderance of abnormalities, including prolongation, multipolarity, misalignment, mitotic catastrophe and loss of spindle checkpoint, that are accompanied by reduced expression of several cell cycle regulators, including Mad2. On the other hand, we also showed that Chk1 deficiency inhibited mammary tumor formation in mice carrying a homozygous deletion of p53, uncovering a complex relationship between Chk1 and p53. Furthermore, inhibition of Chk1 with a specific inhibitor, SB-218078, or acute deletion of Chk1 using small hairpin RNA killed mammary tumor cells effectively. These data show that Chk1 is critical for maintaining genome integrity and serves as a double-edged sword for cancer: although its inhibition kills cancer cells, it also triggers tumorigenesis when favorable mutations are accumulated for cell growth. |
| | |
Authors:
|
T Fishler; Y-Y Li; R-H Wang; H-S Kim; K Sengupta; A Vassilopoulos; T Lahusen; X Xu; M-H Lee; Q Liu; S-J Elledge; T Ried; C-X Deng |
Related Documents
:
|
12711005 - Steroid hormone profile of canine inflammatory mammary carcinoma: a preliminary study. 15466215 - Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibi... 17440055 - Coordinated regulation of pathways for enhanced cell motility and chemotaxis is conserv... 14691145 - Autocrine laminin-5 ligates alpha6beta4 integrin and activates rac and nfkappab to medi... 4053025 - Tumor cell generation of thrombin via functional prothrombinase assembly. 18381935 - Familial breast cancers without mutations in brca1 or brca2 have low cyclin e and high ... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Intramural Date: 2010-05-17 |
Journal Detail:
|
Title: Oncogene Volume: 29 ISSN: 1476-5594 ISO Abbreviation: Oncogene Publication Date: 2010 Jul |
Date Detail:
|
Created Date: 2010-07-15 Completed Date: 2010-08-10 Revised Date: 2011-11-02 |
Medline Journal Info:
|
Nlm Unique ID: 8711562 Medline TA: Oncogene Country: England |
Other Details:
|
Languages: eng Pagination: 4007-17 Citation Subset: IM |
Affiliation:
|
Genetics of Development and Disease Branch, National Institute of Diabetes, Digestive and Kidney Diseases, Bethesda, MD, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Base Sequence DNA Primers Genomic Instability* Mammary Neoplasms, Experimental / genetics*, pathology Mice Mice, Knockout Protein Kinases / genetics* Reverse Transcriptase Polymerase Chain Reaction Spectral Karyotyping Tumor Suppressor Protein p53 / genetics* |
| Chemical | |
Reg. No./Substance:
|
0/DNA Primers; 0/Tumor Suppressor Protein p53; EC 2.7.-/Protein Kinases; EC 2.7.11.1/Checkpoint kinase 1 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Nek7 kinase targeting leads to early mortality, cytokinesis disturbance and polyploidy.
Next Document: SNF5, a core component of the SWI/SNF complex, is necessary for p53 expression and cell survival, in...